Anesthetized female C57/BL/6 J mice were injected intravenously with saline or glucose (0.125, 0.35 or 0.75 g/kg) with or without simultaneous administration of synthetic tirzepatide (3 nmol/kg)
Eating much less than usual, especially skipping meals altogether, may cause blood sugar to dip, which is a recognized headache trigger
[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
This combination shows particular promise for metabolic resilience and muscle preservation during caloric deficit
Many animal studies have been done looking at Alzheimer's disease, a human-like Alzheimer's disease in a rodent, and heat shock proteins protecting from it
Studies published in Journal Nature show the potential of probiotics including Akkermansia muciniphila to support GLP-1 levels
.jpg)
![GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions[v1]](https://www.preprints.org/frontend/picture/ms_xml/manuscript/b0714be486d8e9fe95dfcbc85df1634c/preprints-164552-g001.png)
